As of Nov 6, 2024, R1 RCM's P/E ratio was -65.6, a -3,002.65% change from the 2.26 P/E ratio recorded in the previous year.

The R1 RCM P/E history

R1 RCM Aktienanalyse

What does R1 RCM do?

R1 RCM Inc is an American company that operates in the healthcare services sector. It was founded in 2003 as Accretive Health and is headquartered in Chicago, Illinois. R1 RCM's business model focuses on providing services in the area of Revenue Cycle Management (RCM). This involves managing the payment process between patients, insurance companies, and medical service providers. R1 RCM offers its customers a comprehensive range of RCM services, including Revenue Cycle Analytics, Patient Access, and Revenue Cycle Outsourcing. With this service, R1 RCM provides a solution for all types of customers. The various divisions of R1 RCM include Revenue Cycle Services, Physician Advisory Services, Revenue Integrity, and Population Health. R1 RCM's Revenue Cycle Services encompass both RCM technology and services such as patient billing, revenue cycle outsourcing, coding, and documentation. Physician Advisory Services were created to add value to clinical decisions and build a collaborative partnership between physicians and R1 RCM. Revenue Integrity focuses on auditing billing errors and identifying additional services to improve reimbursement. Population Health focuses on managing population health analytics to determine which patients should be targeted with specific RCM technologies and services. The products offered by R1 RCM help customers streamline the revenue cycle and reduce costs. R1 RCM's product range includes RCM technology, outsourcing services, consulting services, and training materials. These products are used by R1 RCM to enhance the efficiency and effectiveness of RCM processes by simplifying billing, improving cash flow, and strengthening customer retention. R1 RCM has shown positive growth in recent years and acquired Intermedix Corp. in 2017. The acquisition was a significant step for R1 RCM in the post-acute care and ambulatory medical services sector, helping the company expand its business in the retail segment. Overall, R1 RCM has a solid business operation, and the services it offers are indispensable for many medical service providers. With improved technologies and continuous business model enhancements, R1 RCM has the opportunity to continue growing in the coming years. R1 RCM ist eines der beliebtesten Unternehmen auf Eulerpool.com.

P/E Details

Deciphering R1 RCM's P/E Ratio

The Price to Earnings (P/E) Ratio of R1 RCM is a vital metric that investors and analysts use to determine the company’s market value relative to its earnings. It is calculated by dividing the current stock price by the earnings per share (EPS). A higher P/E ratio could suggest that investors are expecting higher future growth, while a lower ratio may indicate a potentially undervalued company or lower growth expectations.

Year-to-Year Comparison

Assessing R1 RCM's P/E ratio on a yearly basis provides insights into the valuation trends and investor sentiment. An increasing P/E ratio over the years signifies growing investor confidence and expectations for future earnings growth, while a decreasing ratio may reflect concerns over the company's profitability or growth prospects.

Impact on Investments

The P/E ratio of R1 RCM is a key consideration for investors aiming to balance risk and reward. A comprehensive analysis of this ratio, in conjunction with other financial indicators, aids investors in making informed decisions regarding buying, holding, or selling the company’s stocks.

Interpreting P/E Ratio Fluctuations

Fluctuations in R1 RCM’s P/E ratio can be attributed to various factors including changes in earnings, stock price movements, and shifts in investor expectations. Understanding the underlying reasons for these fluctuations is essential for predicting future stock performance and assessing the company's intrinsic value.

Frequently Asked Questions about R1 RCM stock

What is the price-to-earnings ratio of R1 RCM?

The price-earnings ratio of R1 RCM is currently -65.6.

How has the price-earnings ratio of R1 RCM changed compared to last year?

The price-to-earnings ratio of R1 RCM has increased by -3,002.65% fallen (meaning "decreased" or "dropped") compared to last year.

What consequences does a high price-earnings ratio have for investors?

A high price-to-earnings ratio indicates that the company's stock is relatively expensive and investors may potentially achieve a lower return.

What does a low price-earnings ratio mean?

A low price-earnings ratio means that the company's stock is relatively cheap and investors may potentially achieve a higher return.

Is the price-earnings ratio of R1 RCM high compared to other companies?

Yes, the price-to-earnings ratio of R1 RCM is high compared to other companies.

How does an increase in the price-earnings ratio of R1 RCM affect the company?

An increase in the price-earnings ratio of R1 RCM would lead to a higher market capitalization of the company, which in turn would lead to a higher valuation of the company.

How does a reduction in the price-to-earnings ratio of R1 RCM affect the company?

A decrease in the price-earnings ratio of R1 RCM would result in a lower market capitalization of the company, which in turn would lead to a lower valuation of the company.

What are some factors that influence the price-earnings ratio of R1 RCM?

Some factors that influence the price-earnings ratio of R1 RCM are the company's growth, financial position, industry development, and the overall economic situation.

How much dividend does R1 RCM pay?

Over the past 12 months, R1 RCM paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, R1 RCM is expected to pay a dividend of 0 USD.

What is the dividend yield of R1 RCM?

The current dividend yield of R1 RCM is .

When does R1 RCM pay dividends?

R1 RCM pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of R1 RCM?

R1 RCM paid dividends every year for the past 0 years.

What is the dividend of R1 RCM?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is R1 RCM located?

R1 RCM is assigned to the 'Health' sector.

Wann musste ich die Aktien von R1 RCM kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of R1 RCM from 11/6/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 11/6/2024.

When did R1 RCM pay the last dividend?

The last dividend was paid out on 11/6/2024.

What was the dividend of R1 RCM in the year 2023?

In the year 2023, R1 RCM distributed 0 USD as dividends.

In which currency does R1 RCM pay out the dividend?

The dividends of R1 RCM are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

The R1 RCM stock can be added to a savings plan with the following providers: Trade Republic

Andere Kennzahlen von R1 RCM

Our stock analysis for R1 RCM Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of R1 RCM Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.